Highview Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Highview Capital Management's LLY Position: Q1 2026 in Review
Highview Capital Management increased its Eli Lilly (LLY) stake by 2% in Q1 2026, buying an estimated $115K and bringing the position to 5,758 shares worth $5.3M. The position accounts for 1.93% of the portfolio, ranked #15.
Highview Capital Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.07M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Highview Capital Management held 5,758 shares of Eli Lilly worth $5.3M as of Q1 2026.
- Highview Capital Management bought 113 Eli Lilly shares in Q1 2026, an estimated $115K.
- Eli Lilly made up 1.93% of Highview Capital Management's portfolio in Q1 2026, its #15 holding.
- Highview Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Highview Capital Management's Eli Lilly position peaked at $6.07M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Highview Capital Management's 13F filing for Q1 2026, filed 8 May 2026.